CELLSHOT ONCO-LAB
DEAD

Serial Number

88661622

Owner

FEMTOBIOMED Inc.

Attorney

James R Menker

Filing Date

Oct 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CELLSHOT ONCO-LAB Trademark

Serial Number: 88661622

CELLSHOT ONCO-LAB is a trademark filed by FEMTOBIOMED Inc. on October 21, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

FEMTOBIOMED Inc. (8 trademarks)

Sampyeong-dong, Pangyo Seven Venture Val
228beon-gil, Bundan Seongnam-si, Gyeongg , KR

Entity Type: 03

Trademark Details

Filing Date

October 21, 2019

Registration Date

Not Registered

Goods & Services

DNA chips; interfacial energy measuring and analyzing apparatus in the nature of force measurement products, namely, digital force gauges, digital torque gauges and manual and motorized test stands used therewith sold as a unit with the gauges, tension testers; optical profilers; data processing apparatus in the nature of digitizers being measuring instrumentation and apparatus; digital measuring apparatus in the nature of digital multimeters; laboratory equipment and supplies, namely, incubators for cell culture; bioreactor for cell culturing; cell measuring apparatus in the nature of electronic apparatus for electrophysiological measurement of cells; free fatty acid measuring and analyzing apparatus for laboratory use being research laboratory analyzers for measuring and analyzing blood and other bodily fluids; intracellular material injector for laboratory use in the nature of injection instrument with needles, needle-based and needle-free injection systems; gene analyzing and extracting devices, namely, laboratory apparatus and instruments for extracting DNA; laboratory apparatus and instruments, namely, gene amplifiers in the nature of DNA microarrays; measuring devices, electric, namely, electronic apparatus for electrophysiological measurement of cells; contact angle measuring and analyzing apparatus, namely, angle finders; precision measuring apparatus, namely, laboratory equipment and supplies, namely, calipers; surveying instruments

Apparatus for use in medical analysis, namely, medical diagnostic apparatus for testing DNA and RNA samples; diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, and DNA; diabetes measuring apparatus being blood glucose meter; medical immunoassay apparatus, namely, immunochemical testing apparatus for medical use; immunoassay apparatus for diagnostic in the nature of medical diagnostic apparatus for detecting cancer, medical diagnostic apparatus for testing DNA and RNA samples; cell culture instruments for medical use, namely, cell culture chambers; free fatty acid measuring device being medical instruments; measuring instruments for medical purposes for measuring and displaying cancer cells, DNA, blood cells and extra cellular contents; cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; apparatus for analysing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; blood testing apparatus; infusion apparatus for therapeutic purposes, namely, medical apparatus, namely, infusion devices for administering drugs

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 16, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 15, 2021 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 3, 2020 GNFN
FINAL REFUSAL E-MAILED
Aug 3, 2020 GNFR
FINAL REFUSAL WRITTEN
Aug 3, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 26, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 28, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jan 28, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jan 28, 2020 CNRT
ASSIGNED TO EXAMINER
Jan 28, 2020 DOCK
TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Nov 26, 2019 TAEA
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 26, 2019 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2019 NWOS